Top 50 Health Care VC Funds & Investors in United Kingdom (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
SFC Capital
VC Fund
|
87 | United Kingdom, United States, Canada | Pre-Seed, Seed | Artificial Intelligence, Software, Information Technology | $131k–$2.2M |
|
Scottish Enterprise
VC Fund
|
72 | United Kingdom, United States, Switzerland | Grant, Seed | Biotechnology, Software, Health Care | $119k–$4.3M |
|
Parkwalk Advisors
VC Fund
|
70 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $1.2M–$45M |
|
UK Innovation & Science Seed Fund
VC Fund
|
66 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Medical | $458k–$14M |
|
Oxford Science Enterprises
VC Fund
|
61 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Software | $1.4M–$168M |
|
Deepbridge Capital
VC Fund
|
48 | United Kingdom, Spain, Australia | Seed, Series A | Health Care, Biotechnology, Medical | $152k–$15M |
|
Development Bank of Wales
VC Fund
|
46 | United Kingdom, Australia, United States | Seed, Debt Financing | Software, Health Care, Manufacturing | $18k–$3.8M |
|
Oxford Technology Management
VC Fund
|
45 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Software | $33k–$7.9M |
|
Northstar Ventures
VC Fund
|
43 | United Kingdom, United States, Indonesia | Seed, Series A | Software, Health Care, E-Commerce | $39k–$10M |
|
Business Growth Fund
VC Fund
|
42 | United Kingdom, Ireland, United States | Venture - Series Unknown, Series A | Software, Manufacturing, Information Technology | $3.5M–$21M |
|
Mercia Fund Managers
VC Fund
|
40 | United Kingdom, United States, Hungary | Seed, Series A | Software, Health Care, Biotechnology | $250k–$14M |
|
Scottish Investment Bank
VC Fund
|
39 | United Kingdom, United States, France | Seed, Series A | Software, Biotechnology, Health Care | $327k–$7.5M |
|
Innovate UK
VC Fund
|
38 | United Kingdom, United States, Ireland | Grant, Seed, Pre-Seed | Health Care, Biotechnology, Software | $57k–$3.7M |
|
SyndicateRoom
VC Fund
|
37 | United Kingdom, United States, India | Seed, Equity Crowdfunding | Health Care, Software, Medical | $244k–$2.7M |
|
AlbionVC
VC Fund
|
36 | United Kingdom, United States, France | Series A, Seed | Software, Information Technology, Health Care | $2.2M–$19M |
|
Catapult Ventures
VC Fund
|
33 | United Kingdom, United States, Israel | Seed, Series A | Health Care, Biotechnology, Medical | $150k–$26M |
|
Cambridge Angels group
VC Fund
|
33 | United Kingdom, United States, Estonia | Seed, Series A | Software, Health Care, Biotechnology | $382k–$9.5M |
|
Future Planet Capital
VC Fund
|
33 | United Kingdom, United States, Spain | Seed, Convertible Note | Biotechnology, Health Care, Software | $688k–$5.5M |
|
SOSV
VC Fund
|
33 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
IP Group
VC Fund
|
31 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $393k–$30M |
|
Archangels
VC Fund
|
30 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $1.3M–$8.3M |
|
Octopus Ventures
VC Fund
|
30 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $2.1M–$44M |
|
Calm/Storm VC
VC Fund
|
30 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $538k–$18M |
|
Newable Private Investing
VC Fund
|
28 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $196k–$5.2M |
|
Salica
VC Fund
|
28 | United Kingdom, United States, Germany | Seed, Secondary Market, Series A | Software, Information Technology, Health Care | $1M–$346M |
|
Praetura Ventures
VC Fund
|
27 | United Kingdom, Australia, Germany | Seed, Venture - Series Unknown | Software, Information Technology, Health Care | $622k–$9M |
|
Ascension
VC Fund
|
27 | United Kingdom, United States, Italy | Seed, Pre-Seed | Software, FinTech, Internet | $229k–$5.1M |
|
Oxford Capital
VC Fund
|
26 | United Kingdom, United States, France | Seed, Series A | Software, Health Care, Biotechnology | $1.5M–$16M |
|
Foresight Group
VC Fund
|
26 | United Kingdom, United States, Ireland | Private Equity, Seed | Software, Manufacturing, Information Technology | $655k–$9.4M |
|
Techstart Ventures
VC Fund
|
25 | United Kingdom, Ireland, United States | Seed, Pre-Seed | Software, Information Technology, Health Care | $100k–$4M |
|
Mercia Asset Management
VC Fund
|
24 | United Kingdom, United States | Series A, Seed | Software, Information Technology, Health Care | $524k–$13M |
|
Epidarex Capital
VC Fund
|
24 | United Kingdom, United States, Germany | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $531k–$48M |
|
Antler
VC Fund
|
24 | Singapore, Australia, United Kingdom | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
Midlands Engine Investment Fund
VC Fund
|
24 | United Kingdom, United States, Portugal | Debt Financing, Seed | Software, Health Care, Manufacturing | $262k–$2.6M |
|
Hoxton Ventures
VC Fund
|
24 | United Kingdom, United States, Canada | Seed, Series A, Series B | Artificial Intelligence, Software, Health Care | $1.9M–$35M |
|
Kindred Capital
VC Fund
|
23 | United Kingdom, United States, Germany | Seed, Series A, Series B | Software, Biotechnology, Health Care | $1.5M–$73M |
|
GM&C Life Sciences Fund
VC Fund
|
23 | United Kingdom, Italy, Germany | Seed, Series A | Health Care, Biotechnology, Medical | $131k–$4.1M |
|
Redbus Ventures
VC Fund
|
22 | United Kingdom, United States, Australia | Seed, Series A, Pre-Seed | FinTech, E-Commerce, Health Care | $42k–$23M |
|
Kelvin Capital
VC Fund
|
22 | United Kingdom, United States | Seed, Venture - Series Unknown | Health Care, Biotechnology, Manufacturing | $144k–$5M |
|
The FSE Group
VC Fund
|
22 | United Kingdom, United States, Canada | Seed, Debt Financing | Software, Manufacturing, Information Technology | $111k–$2.1M |
|
O2h Ventures
VC Fund
|
21 | United Kingdom, Hungary | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Pharmaceutical | $603k–$25M |
|
24 Haymarket
VC Fund
|
21 | United Kingdom, United States | Seed, Series A | Health Care, Software, Biotechnology | $714k–$16M |
|
Sofinnova Partners
VC Fund
|
20 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6.6M–$109M |
|
IQ Capital
VC Fund
|
20 | United Kingdom, United States, Germany | Seed, Series A | Software, Artificial Intelligence, Machine Learning | $1.3M–$40M |
|
Meltwind Advisory
VC Fund
|
20 | United Kingdom, United States | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Therapeutics | $996k–$94M |
|
Eos
VC Fund
|
20 | United Kingdom, Ireland, United States | Seed, Series A | Biotechnology, Health Care, Medical | $1.5M–$47M |
|
Clarendon Fund Managers
VC Fund
|
20 | United Kingdom, United States, Ireland | Seed, Venture - Series Unknown | Software, Health Care, Biotechnology | $440k–$6.7M |
|
Downing Ventures
VC Fund
|
20 | United Kingdom, United States, Israel | Series A, Seed | Software, Health Care, Information Technology | $550k–$13M |
|
Maven Capital Partners
VC Fund
|
20 | United Kingdom, United States, Germany | Seed, Venture - Series Unknown | Software, Information Technology, SaaS | $655k–$8.3M |
|
Cambridge Innovation Capital
VC Fund
|
20 | United Kingdom, United States, Ireland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2.5M–$73M |
| Access all 3093 VC funds in United Kingdom Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 578
- Round size: Seed $131k–$2.2M; Pre-Seed $173k–$846k
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Keylr — Services partner for property managers. Book reliable, top-rated professionals for your properties with e-props.
- Furbnow — Furbnow - Your companion for home improvements for the future
- Checkboard — Complete your identity verification and payments without the paperwork. Checkboard handles your ID, open banking, and payments from one app.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 386
- Round size: Seed $381k–$4.3M; Grant $119k–$4.2M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- QuickBlock — QUICKBLOCK delivers training environments, deployable infrastructure and force protection solutions for defence and security organisations worldwide.
- Cirrus Logic — Cirrus Logic, Inc. is a premier supplier of high-precision analog and digital signal processing components for audio and energy markets.Founded in 1984, Cirrus Logic excels at developing complex chip designs where feature integration and innovation is a premium. Cirrus Logic has more than 1,000 patents that are key to our more than 700 productsserving more than 2,500 end customers globally, through both direct and distributor-based channel sales.
- Incremental Group — Incremental Group provides software consultancy and analytics services to clients in oil and gas, financial services, and the public sector.
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 289
- Round size: Seed $1.2M–$4.8M; Series A $1.6M–$15M; Series B $2M–$45M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Psyomics — Technology to support better mental health assessment - accelerating patients to the right care pathway, first time.
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 144
- Round size: Seed $458k–$5.9M; Series A $2.9M–$14M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- MFX — MFX develops microfluidic-based platforms for cell and gene therapy development and manufacturing
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- Halo X Ray Technologies — HALO X-ray Technologies - next generation X-ray diffraction technology for the aviation security, medical and process control markets.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 195
- Round size: Seed $1.4M–$12M; Series A $6.3M–$45M; Series B $13M–$168M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $327M in 2022
Portfolio highlights
- AlveoGene — Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Scripta Therapeutics — Biology decoded, disease undone - modulating transcription factors to restore health
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Spain, Australia
Investor stats
- Total investments: 91
- Round size: Seed $152k–$2.4M; Series A $2M–$15M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.4M in 2022
Portfolio highlights
- upLYFT — upLYFT is working on the next generation of smart wearables to help with musculoskeletal issues related to aging. Also working with pro athletes to help sporting individuals train harder and break records.
- GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 248
- Round size: Seed $360k–$3.3M; Debt Financing $18k–$3.8M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $25M in 2018
Portfolio highlights
- Wagonex — Car subscription is the new, all-inclusive, flexible alternative to leasing. No large downpayment and a single fixed monthly payment. Just add fuel and go.
- Jehu Group — The Jehu Group is a third generation family owned business with over 80 years of successful trading history.We mange our operations on a day-to-day basis through three trading subsidiaries. Each subsidiary is supported by Jehu Group Limited which provides finance, HR, technical and procurement functions.In all of our markets, we position ourselvesas a dynamic and bespoke alternative to national contractors and house builders and are proud of our strong reputation in the market place.
- Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 110
- Round size: Seed $33k–$2.2M; Series A $786k–$7.9M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- CryoLogyx — CryoLogyx Ltd. trading as CryoLogyx registered in England and Wales 13078280. VAT registered 373846855. Our registered office address is CryoLogyx Ltd, The Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ.
- Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 208
- Round size: Seed $39k–$2.1M; Series A $295k–$10M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- H2CHP — H2CHP's Free Piston Engine Technology enables your transition to green energy with the reliability & confidence of fuel flexibility.
- NunaBio — NunaBio operates as a privately-owned specialist DNA development company. NunaBio engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities.
- Advanced Electric Machines — Our magnet free motors help manufacturers build more sustainable vehicles and products. See how we can help you today.
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 416
- Round size: Series A $3.9M–$21M; Venture - Series Unknown $3.5M–$19M
- Lead/follow: 85% lead, 15% follow
- Last fund: Likely still investing — raised $102M in 2022
Portfolio highlights
- TMT ID — A leading provider of global mobile and device intelligence. We power leading identity providers, A2P SMS messaging companies and financial organisations.
- UK Flooring Direct — Transform your home with UK Flooring Direct. Shop wood, laminate, & vinyl flooring at great prices with fast UK delivery & expert advice.
- Thames Card Technology —
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 139
- Round size: Seed $250k–$2M; Series A $2M–$14M
- Lead/follow: 67% lead, 33% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
- Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
- MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 216
- Round size: Seed $327k–$3.1M; Series A $1.6M–$7.5M
- Lead/follow: 10% lead, 90% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
- Administrate — Manage instructor-led training with Administrate. Plan, schedule, communicate, resolve issues, and report on training operations from one platform.
Innovate UK is part of the UK Research and Innovation .
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Grant, Seed, Pre-Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 926
- Round size: Seed $349k–$3.7M; Grant $62k–$1.8M; Pre-Seed $57k–$1.5M
- Lead/follow: 79% lead, 21% follow
Portfolio highlights
- Icaruus — Icaruus designs and manufactures apparel for brands, designers, and companies using local, on-demand manufacturing supply chains. Icaruus has completed several projects to expand circular manufacturing and apparel data analytics in the UK and works with many sustainable fashion partners to develop software and hardware solutions for apparelmanufacturing.
- Your FLOCK — Your FLOCK helps teams stay together longer by increasing employees engagement by asking the right questions based on a team member's values.
- Symbiosis Pharmaceutical Services — Symbiosis Pharma is a biologics CMO offering rapid access to aseptic fill finish manufacturing slots across vaccines, ATMPs, mAbs & more
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Equity Crowdfunding
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 144
- Round size: Seed $360k–$2.7M; Equity Crowdfunding $244k–$1.6M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- ManaMind — Human-like testing at machine scale. ManaMind delivers fully autonomous QA testing for video games - zero-shot, no code access, infinitely scalable.
- Xperiome — Match research-ready members to clinical and real-world studies, faster and smarter than ever before through data-driven insights into the rare disease experience.
- Joyvié — Joyvié Health designs medical continence products focused on managing severe faecal incontinence. The company is developing a patent-pending class of non-invasive faecal management briefs that prevent stool from contacting the skin. By separating waste from the body, the underwear aims to lower the risk of skin breakdown and secondary infectionwhile reducing the physical and emotional strain on caregivers. Joyvié Health works with care providers to pilot its products in real-world care environments and gather clinical and user feedback. Its offering is intended for adults with continence needs in institutional and home care settings, and for professionals responsible for continence care. The company also engages with investors and partners to advance product development and clinical evaluation.
AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Seed
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 175
- Round size: Seed $2.2M–$12M; Series A $3.9M–$19M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- uMotif — uMotif provides the most modern eCOA/ePRO and eConsent platform designed to power clinical and real-world research.
- Hussle — Gym membership with total flexibility. Gym passes to no contract gym memberships that you can use in thousands of gyms across the UK. Gym and swim wherever you want to. Stop and start whenever you like.
- Gravitee — Open Source API Management Platform - Gravitee
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $150k–$5.6M; Series A $1.6M–$26M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Estonia
Investor stats
- Total investments: 138
- Round size: Seed $382k–$3M; Series A $2M–$9.5M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- MNS — Transforming global healthcare with self-administered microneedle vaccine patches. Safe, efficient, and accessible- bringing vaccinations to homes worldwide.
- Orthofuse — Orthofuse designs and manufacturers advance orthopaedic solutions using 3D printing technology. Their focus is on bringing precision and simplicity to complex surgical procedures, creating implants and systems that fit naturally into a surgeon's workflow while delivering dependable outcomes.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 181
- Round size: Seed $688k–$5.5M
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely still investing — raised $23M in 2022
Portfolio highlights
- Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
- Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 206
- Round size: Seed $393k–$8.5M; Series A $2.4M–$30M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $125M in 2014
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Oxa — Autonomous Vehicle Software - Any Vehicle, Any Place, Any Time
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 85
- Round size: Seed $1.3M–$3.9M; Series A $1.6M–$8.3M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- BioCaptiva — BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers.
- Bioliberty — Engineering the future of physical and occupational therapy.
- Earth Blox — Earth Blox provides a platform for analyzing geospatial data through a visual interface for environmental and land analysis. The system enables users to build workflows using satellite imagery and other earth observation datasets without requiring extensive coding knowledge. It supports applications such as deforestation tracking, carbonmonitoring, agriculture assessment, and land use analysis.The platform integrates data sources and processing tools to help users generate insights, automate analyses, and export results for reporting or further use. It also allows collaboration across teams by sharing workflows and outputs within a unified environment. Earth Blox supports organizations working with geospatial intelligence by simplifying access to large-scale environmental data and analysis tools.
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 400
- Round size: Seed $2.1M–$12M; Series A $3.3M–$22M; Series B $8M–$44M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $101M in 2019
Portfolio highlights
- geoSurge — Customers don't search. They ask.
- Grasp — Grasp is the world's first AI analyst for finance professionals. Our AI analyst automates company and market research for investment banks, private equity firms, and management consulting firms across the world.
- Monkey Bizness — Monkey Bizness is the largest provider of indoor family entertainment centres in the UK. Each centre includes a children's soft play area and is designed to provide a safe, clean and fun environment in which parents and children can feel comfortable. Monkey Bizness' centres provide a setting that encourages children to express themselvesthrough creativity and play as well as providing fresh and nutritious food to keep kids happy and healthy.Monkey Bizness currently has centres in eight locations: Lewes, Gosport, Poole, Sheffield, Stevenage, Hull Edinburgh and Glasgow.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 135
- Round size: Seed $1.3M–$6.5M; Pre-Seed $538k–$2.6M; Series A $7.6M–$18M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $23M in 2020
Portfolio highlights
- Apylon — Intelligent Revenue Management™ for European Healthcare
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- SquareMind — SquareMind redefines skin exams with Swan, the world's first full-body dermoscopy robot. Automated, seamless, and powered by AI technology.
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 104
- Round size: Seed $196k–$3.1M; Series A $1.3M–$5.2M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Founded as an investment firm focusing on the most promising startups, we have evolved into a unique set of private market funds investing globally in equity and debt across complementary sectors and stages. We fuse traditional values with a contemporary approach and balance exacting processes with the agility to capture commercial opportunity andcompelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of complementary funds and relationships.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Secondary Market, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 217
- Round size: Seed $1M–$5M; Series A $5M–$21M; Secondary Market $60M–$346M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Moneybox — Moneybox is the simple way to save, invest, buy your first home, and combine your old pensions - all with one award-winning app. Download now.
- CameraMatics — Digitize fleet management to optimize performance. Onboard sensors, smart cameras, & apps to mitigate risk, manage safety & achieve sustainability goals.
- Modern Milkman — Modern Milkman is a Yorkshire-based milk delivery company.
Praetura Ventures has been supporting entrepreneurs with more than money since 2011. Click to find out more about how we can help businesses and investors.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, Australia, Germany
Investor stats
- Total investments: 165
- Round size: Seed $622k–$4.5M; Venture - Series Unknown $1.6M–$9M
- Lead/follow: 79% lead, 21% follow
Portfolio highlights
- Peak — Accelerating AI adoption in retail and manufacturing, driving growth through inventory optimisation, AI-driven pricing, and more.
- RapidSpike — Keep your website online, boost performance and improve your digital experience to increase customer conversions.
- We Influence — We Influence is a digital marketing agency specializing in search marketing and conversion rate optimization. The company also specializes in PPC, SEO, affiliate, social media, and content marketing, working with eCommerce brands across the UK to help catapult them to the next level of their growth. They help reach more potential customers throughsocial media channels to boost profitability and brand reach.We Influence transforms their clients’ businesses by catapulting them to the next level of their e-commerce growth.
Pre-seed and seed investors backing 300+ ambitious founders from day one.
Show more...Investment focus
- Industry: Software, FinTech, Internet
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, United States, Italy
Investor stats
- Total investments: 240
- Round size: Seed $229k–$5.1M; Pre-Seed $379k–$2.5M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — raised $22M in 2024
Portfolio highlights
- Qureight — Pioneering data curation to solve complex diseases
- Merx — Grow contactability, data quality and customer lifetime value with AI agents on WhatsApp.
- GEEIQ — GEEIQ is the intelligence platform brands use to plan, activate and measure marketing in virtual worlds like Roblox, Fortnite and ZEPETO.
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 150
- Round size: Seed $1.5M–$3.9M; Series A $3.2M–$16M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $56M in 2015
Portfolio highlights
- Moneybox — Moneybox is the simple way to save, invest, buy your first home, and combine your old pensions - all with one award-winning app. Download now.
- Hometree — Keep yourself warm with Hometree, and try our no price hike promise. Compare our different boiler & home cover plans to see how you can save.
- Oxford Quantum Circuits — Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies.
Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices,private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Private Equity, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 206
- Round size: Seed $655k–$9.4M; Private Equity $2.1M–$8.3M
- Lead/follow: 65% lead, 35% follow
Portfolio highlights
- Roma Finance — At Roma Finance, we pride ourselves on offering a borrower first experience for those in property investment and development.
- AcroSoft — OnBase is a content services platform for managing content, processes and cases. It unites all your critical systems and information.
- Envair Technology — Your single source provider of next generation isolators, fume cupboards, downflow booths, biosafety cabinets and other clean air systems.
Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 183
- Round size: Seed $326k–$4M; Pre-Seed $100k–$1.3M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Saltroad — Get matched with an experienced HCPC Speech and Language Therapist based on your child's needs, your budget and your schedule. Loved by parents & children.
- Product Guru — Although there has been a significant change of pace in the technology used within the retail sector, the process of finding the products that drive the market has really remained at a stand-still. With more and more small, specialist suppliers driving innovation in the sector, it has been harder than ever for buyers to be able to consider alloptions.
- Cloudsmith — Cloudsmith is the only universal, cloud-native solution for software artifact management and software supply chain security. Start your free trial today.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 101
- Round size: Seed $524k–$3.1M; Series A $2.2M–$13M
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Netacea — Netacea takes a smarter approach to bot management. Intent Analytics™ powered by machine learning quickly and accurately distinguishes bots from humans to protect websites, mobile apps and APIs from automated threats while prioritising genuine users. Actionable intelligence with data-rich visualisations empowers you to make informed decisions aboutyour traffic. The Netacea approach offers incredible speed, accuracy and transparency, solving the growing problem of credential stuffing and account takeover at scale. The technology is designed to complement existing controls such as WAF rulesets, rate limiting and threat databases to provide a deep analysis of all website visitors, actionable intelligence and real-time threat.The Netacea approach continuously monitors your web traffic to pinpoint the difference in automated bot activity vs genuine visitors, keeping you ahead of evolving bot threats. Choose to automatically block, redirect or challenge automated attacks in real-time, or receive alerts notifying you of potential threats. With access to rich dashboards and data, you can easily identify and stop account takeover attempts early in the attack chain.Learn more at www.netacea.com
- Semble — The integrated clinical system for managing your patients' medical data and admin tasks.
- Locate Bio — Locate Bio is a regenerative medicine development company focused on orthobiologics. Locate Bio exists to help surgeons improve the lives of people with debilitating spinal conditions. We are curious about what is possible, but ground all our work in robust scientific evidence. We relentlessly pursue high-value opportunities with clear unmetclinical needs.
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 50
- Round size: Seed $531k–$8.5M; Series A $2.6M–$38M; Series B $2.4M–$48M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
- Epsilogen — IGEM Therapeutics is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.The company's offerings include IgE-based drugs targeting solid tumors, enabling patients to kill parasites which reside in human tissue, also the home of the solid tumor.
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Singapore, Australia, United Kingdom
Investor stats
- Total investments: 2216
- Round size: Seed $159k–$4.6M; Pre-Seed $100k–$645k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $72M in 2024
Portfolio highlights
- Praktiki — Praktiki is building the "Decision Layer" for medicine.While medical knowledge doubles every 73 days, frontline clinicians struggle to translate guidelines into practice. Current AI search tools excel at surfacing public data from clinical trials, but fail to capture "how" experts apply that evidence in real-world scenarios.Praktiki fills this gap. We utilise an AI Agentic Creator Engine to capture tacit specialist reasoning and fuse it with public evidence. This feeds a proprietary Expert Knowledge Graph that powers: 1) Microlearning: Case-based modules created 10x faster and which are 170% more effective than traditional education 2) AI Expert Guidance: Real-time decision support synthesising evidence with expert implementation strategies.2025 Traction - our MVP proved that solving the expertise gap drives high engagement: - Registered >10% of UK GPs - 60,000+ modules completed with an 85% completion rate - 51% month-over-month growth - Market-leading NPS of 83We are building a compounding data moat to expand beyond education into clinical intelligence and healthcare data solutions.
- Mast — Mast is the cloud-native, fully configurable loan origination platform empowering lenders to process applications faster and smarter. We make lending better, smoother and faster.
- Forti Foods — The mission of Forti Foods is to enhance communities and change lives beyond the plate by fostering resilience and dignity via sustainable food innovation.
MEIF is an investment firm that operates equity and debt investment towards growth capital. The firm aims to transform the finance landscape for smaller businesses in the Midlands and to realize the region’s potential to achieve economic growth through enterprise. It is a collaboration between the British Business Bank and ten Local EnterprisePartnerships (LEPs) in the West Midlands and East and South East Midlands. MEIF provides over £250m of investment to boost small and medium business (SME) growth in the Midlands.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Debt Financing, Seed
- Geography: United Kingdom, United States, Portugal
Investor stats
- Total investments: 129
- Round size: Seed $327k–$2.6M; Debt Financing $262k–$1.4M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Utility Stream — As business energy brokers, USL was founded with one key mission, simplify business energy for all of our clients & help create a more sustainable world
- School of Coding — School of Coding is affiliated with the reputated org, invites you to apply for sept. intake Explore our courses and start your world-class education.
- Chevin Fleet Solutions — Best Fleet Management Software. Gain real-time insights into your fleet, automate processes, and configure the fleet software to suit your business.
Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 137
- Round size: Seed $1.9M–$12M; Series A $5M–$28M; Series B $6M–$35M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Preply — Looking for a tutor? Preply is the best platform for private online lessons with a flexible payment system and affordable prices. Book your first lesson.
- Behavox — Behavox is an enterprise platform that unifies all types of data into a single data lake, allowing users to query the data and apply machine learning to identify capital markets misconduct and insider threats.Separate Behavox installations form the network defence that aggregates misconduct detection algorithms. The network then uses machinelearning and AI to optimise detection algorithms and suggest new ones. This innovation enables the “brains” to the system to continuously improve and evolve.Complex, high-load and sophisticated engineering is at the core of all the products that Behavox develops to enable deployment at the largest institutions in financial services. They are taking cutting-edge academic research and applying it to enterprise problems that require complex backend engineering with large-scale production footprint.
- Fabrica AI — Fabrica AI offers a revolutionary platform for faster robot development, using custom hardware designs and learned optimal control to increase efficiency while minimizing complexity and cost. With a vision for a future where robot development takes days, not years.
A new model for Venture Capital where every founder we back becomes a co-owner of the fund.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 118
- Round size: Seed $1.5M–$18M; Series A $7.9M–$35M; Series B $13M–$73M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- BEIT — Beit designs and implements an algorithm for solving a relevant NP-complete class of problems using Quantum Computers, getting speedups better than quadratic, guaranteed by theory. Beit focuses on Hamiltonian cycle problem. NP-complete problems are abstractions relevant for many real world problems encountered in logistics, manufacturing, andwarehousing at scale.Beit is headquartered in Kraków, Poland.
- Paddle — Increase revenue, reduce risk and reduce cost with Paddle, the payment solution powering global revenue for n8n, Letterboxd & AdGuard. One platform that handles billing, tax and compliance.
- how.fm — Training software for better onboarding processes and digital store floor management. Train staff with no effort and language barriers.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 34
- Round size: Seed $131k–$1.9M; Series A $1.8M–$4.1M
- Lead/follow: 68% lead, 32% follow
Portfolio highlights
- Gendius — Gendius was founded by Chris Genders and Rory Cameron with a view to making living with diabetes easier. The company has developed Intellin® - an App platform that uses an individual’s clinical history to predict those areas most likely of developing complications from their diabetes i.e. their individual high-risk areas. The platform then focussesthe individual on clinically validated tasks and measures to slow their progression in these areas.
- Maxwellia — A contraceptive pill, Lovima, is now available to buy without a prescription.
- Nexus Labs (Surgical Teaching) — Nexus Labs is an interactive learning resource for medical students.
Redbus Group is a UK based investment group that invests in early stage ventures and funds or acquires businesses that require restructuring. Redbus Group came into existence as an offshoot of Redbus Film Distribution which was founded in 1997 as a film distribution company. Redbus Film Distribution had rapidly established itself as one of thelargest and most profitable film distributors in the UK. In late 2000 it was sold to Helkon Media AG.Redbus through its subsidiary Filmgroup was the first company in Europe to successfully develop technology to compress and stream moving images over the internet. Between 2000 and 2004 Redbus was the UK's fastest growing company with a compound annual growth rate in-excess of 280%. In 2005 Redbus sold its production and distribution operations to Lionsgate Inc and sold its stake in Lovefilm of which it was co-founder, to Amazon in 2010.Employing an entrepreneurial and disciplined approach, Redbus, either with partners or alone looks for opportunities to leverage off its capital, market knowledge and management resources.
Show more...Investment focus
- Industry: FinTech, E-Commerce, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 115
- Round size: Seed $655k–$5.7M; Pre-Seed $42k–$1.6M; Series A $5.4M–$23M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- SOLVE — SOLVE have developed novel transient flow techniques that extend the capabilities of current approaches. SOLVE’s products leverage technology for the efficient collection of data from chemical reactions, as well as predictive computational models tuned based on the collected data. Both the data by itself, as well as the models, are used to informthe reaction conditions and solvent mixtures applied to manufacture chemical compounds at different scales of production.
- Tolemy Bio — The AI-native virtual cell platform for therapeutic development and manufacture.
- Nila Elder Care — With Nila's certified carers, your family back home receives compassionate, professional support, so you never have to worry from afar
Kelvin Capital was founded in 2009 and has since raised a total of over £50million into 28 portfolio companies. We invest venture capital in revenue generating growth companies which have the potential to deliver significant return to their investors. They also invest in companies that require capital to grow their business. For the right companywith the right team, Kelvin Capital provides the investment and the support needed to deliver the true potential of their business.The Kelvin Capital team has a combined 30 years experience of working with new businesses and understands both the challenges and opportunities, which will be encountered during the high growth phase. The team has built up extensive networks, which will be made available to assist and support the portfolio businesses. Kelvin Capital will actively promote the portfolio businesses through its website and social media activities raising their awareness and profile. The entire Kelvin Capital team is focused on the success of their portfolio of businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States
Investor stats
- Total investments: 89
- Round size: Seed $144k–$1.7M; Venture - Series Unknown $741k–$5M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- novosound — Novosound is an award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
- Aurora Avionics — Accelerating launch-vehicle development with flexible and modular avionics platforms.
- Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
FSE C.I.C. is an independent not-for-profit Community Interest Company (C.I.C.) whose surpluses are reinvested in the business, rather than being driven by the need to maximise profit for shareholders and owners. FSE C.I.C. has a number of subsidiary companies to deliver its funds and services, which are collectively referred to as The FSE Group.All regulated activities are delivered through FSE Fund Managers Limited, which is authorised and regulated by the Financial Conduct Authority.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Debt Financing
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 205
- Round size: Seed $312k–$2.1M; Debt Financing $111k–$786k
- Lead/follow: 71% lead, 29% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Alvant — Alvant is an advanced materials technology group specialising in the design, development and production of aluminium composite components for demanding engineering applications.
- Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
- Amino —
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Transforming UK biotech breakthroughs into impact. o2h Ventures offers SEIS/EIS and growth-stage funds to back visionary teams from seed to clinical success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 49
- Round size: Seed $603k–$7.5M; Series A $1.9M–$25M; Venture - Series Unknown $1.1M–$2.9M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
- Atelerix — Discover Atelerix's hypothermic hydrogels for reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples.
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 107
- Round size: Seed $714k–$3.8M; Series A $1.6M–$16M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- DefiniGEN — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
- Previsico — Discover Previsico's real-time flood forecasting solutions, designed to mitigate risks for businesses and communities worldwide.
- Kelda Technology — Kelda Technology is a British clean tech business that develops water-in-air shower products that halve water usage and water heating costs through patented shower technology. Kelda Technology has adapted cutting edge automotive and aerospace technology to produce a revolutionary “water-in-air” shower system that halves water use without any lossin performance. Water is broken into droplets to form a comfortable spray which is accelerated using a globally patented jet-type nozzle. Not only does it halve water costs, but also halves associated heating costs.The Kelda shower system holds appeal for a wide range of sectors, including gym and leisure, hotels and accommodation providers, healthcare, and maritime – all industries where water efficiency is key. The product has completed in-market validation and commercial trials, is in manufacture and the company has already signed installation deals with some of the largest leisure operators in the UK and Latin America.Kelda Technology was recently chosen as one of the top 30 cleantech companies in the world at the New Energy Start-Up awards 2016 and was this week shortlisted by the UK Business Angels Association for Best Investment in a Disruptive Tech Business.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 329
- Round size: Series A $6.6M–$70M; Series B $10M–$109M; Series C $12M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
- Comet Biorefining — Comet Biorefining is a leading provider of sustainable high-quality cost-competitive cellulosic glucose technology for applications in renewable biofuels and biochemicals. The company’s proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosicglucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. Demonstrated at 5 dry tons per day scale, Comet is focusing on commercial scale up and development of commercial partnerships with applications in renewables industries.
IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 205
- Round size: Seed $1.3M–$12M; Series A $4.5M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- RevEng — RevEng.AI is a cyber security and artificial intelligence company that helps organizations understand their cyber security supply chain. RevEng.ai identifies fundamental components of closed-source program binaries and generates real-valued vector embeddings for each component.
- Dataswyft — Infrastructure for Decentralized Data Storage, Mobility and Interoperability
- Imperagen — Imperagen is a biotechnology research company focused on enzyme engineering, artificial intelligence, and synthetic biology.
Meltwind Advisory.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 32
- Round size: Seed $1.2M–$16M; Pre-Seed $996k–$2.5M; Series A $2.9M–$94M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- IMU Biosciences — IMU is a discovery engine mapping the immune system to advance precision medicine.
- Qureight — Pioneering data curation to solve complex diseases
- Syndex Bio — Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.
Eos invests in, & commercialises, science & technology, from local seed-stage to global scale, with a focus on improving lives.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 43
- Round size: Seed $1.5M–$11M; Series A $1.6M–$47M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- TaiSan — A polymer-electrolyte sodium battery for the e-bike and scooter fleet.
- Nami Surgical — Despite advances in robotic surgery, integrated ultrasonic energy remains unavailable in wristed robotic surgical systems.
- Scarlet Therapeutics — Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
We ensure that businesses in Northern Ireland with growth aspirations can access equity finance to reach their potential.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 68
- Round size: Seed $440k–$2.6M; Venture - Series Unknown $1.6M–$6.7M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $17M in 2003
Portfolio highlights
- Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- PathXL — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- LifeCellsNI — LifeCellsNI is committed to offering families and people throughout Northern Ireland and Ireland state-of-the-art stem cell extraction and storage services.
The opportunity for institutional investors to access leading UK early stage healthtech businesses
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 131
- Round size: Seed $550k–$4.7M; Series A $3.2M–$13M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $2.8M in 2014
Portfolio highlights
- TidalSense — CRiL was formed in April 2013 specifically to develop innovative medical devices to diagnose and manage respiratory conditions. They have been building a platform technology, N-Tidal, based on the measurement and analysis of tidal breathing CO2 throughout the entire breath.
- Baby2Body — Nearly 3 million women have used Baby2Body during their fertility, pregnancy, and postpartum journeys. Helping women around the world live healthier and happier with personalized fitness, nutrition, and wellness programs.
- Hummingbird Technologies — Hummingbird Technologies is an artificial intelligence SaaS platform using the latest deep learning and computer vision techniques along with proprietary algorithms to provide actionable intelligence to farmers and agri-businesses at key decision-making times in the growing season. The company analyses remote sensing data to help farmers identifyearly problems in their crops such as crop health, disease risk & detection, weed mapping and yield prediction as well as valuable information such as canopy coverage, plant counting, size and biomass estimation, with the objective of optimising inputs and maximising efficiency. Hummingbird began operating in 2016 and since then has covered in excess of >500,000 hectares of arable crops for farmers and agri-businesses. Their platform is utilised at key decision-making points in the growing season to allow intelligent and specific information to inform chemical or operational input decisions that decrease costs and improve outputs.
Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 205
- Round size: Seed $655k–$5.3M; Venture - Series Unknown $1.2M–$8.3M
- Lead/follow: 74% lead, 26% follow
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- HubIsoft Group — A new class of data technology. You drive, decide where you go and how you navigate, explore areas you thought unfathomable, you are in complete control.
- ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 104
- Round size: Seed $2.5M–$31M; Series A $2.6M–$73M; Series B $8.5M–$66M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
- Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
- TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
Health Care VC funding in United Kingdom at a glance
Stats across 5.5k deals from 3.1k investors.
Access all 3093 VC funds in United Kingdom Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 3093 VC funds investing in United Kingdom Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!